N-Glycosylation Profiles of the Green Microalgae Chlorella Zofingiensis
Abstract
Keywords
Supporting Institution
Project Number
Thanks
References
- 1. G. Walsh, Biopharmaceuticals: biochemistry and biotechnology, John Wiley & Sons2013.
- 2. N.K. Tripathi, A. Shrivastava, Scale up of biopharmaceuticals production. Nanoscale Fabrication, Optimization, Scale-Up and Biological Aspects of Pharmaceutical Nanotechnology, Elsevier2018, pp. 133-172.
- 3. A.F. Jozala, D.C. Geraldes, L.L. Tundisi, V.d.A. Feitosa, C.A. Breyer, S.L. Cardoso, P.G. Mazzola, L.d. Oliveira-Nascimento, C.d.O. Rangel-Yagui, P.d.O. Magalhães, Biopharmaceuticals from microorganisms: from production to purification, Braz. J. Microbiol. 47 (2016) 51-63.
- 4. D.C. Andersen, L. Krummen, Recombinant protein expression for therapeutic applications, Curr. Opin. Biotechnol. 13(2) (2002) 117-123.
- 5. R. Kothari, A. Pandey, S. Ahmad, A. Kumar, V.V. Pathak, V. Tyagi, Microalgal cultivation for value-added products: a critical enviro-economical assessment, 3 Biotech 7(4) (2017) 243.
- 6. O. Pignolet, S. Jubeau, C. Vaca-Garcia, P. Michaud, Highly valuable microalgae: biochemical and topological aspects, J. Ind. Microbiol. Biotechnol. 40(8) (2013) 781-796.
- 7. R. Mócsai, R. Figl, C. Troschl, R. Strasser, E. Svehla, M. Windwarder, A. Thader, F. Altmann, N-glycans of the microalga Chlorella vulgaris are of the oligomannosidic type but highly methylated, Sci. Rep. 9(1) (2019) 1-8.
- 8. E. Becker, Micro-algae as a source of protein, Biotechnol. Adv. 25(2) (2007) 207-210.
Details
Primary Language
English
Subjects
Engineering
Journal Section
Research Article
Authors
Erdinç Aladağ
0000-0003-1354-0930
Türkiye
Yücel Kadıoğlu
0000-0001-6590-7306
Türkiye
Bekir Salih
0000-0002-8542-6531
Türkiye
Publication Date
February 8, 2021
Submission Date
April 9, 2020
Acceptance Date
January 18, 2021
Published in Issue
Year 2021 Volume: 49 Number: 2